1 | 881995-69-3 | (3R)-3-氨基-4-(2,4,5-三氟苯基)丁酸甲酯 | Benzenebutanoic acid, b-amino-2,4,5-trifluoro-, methyl ester, (bR)- | C11H12F3NO2 | |
2 | 88546-55-8 | 埃索美拉唑EP杂质D | 6-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfonyl}-1H-benzimidazole | C17H19N3O4S | |
3 | 5233-42-1 | 5 - 氯氢氯噻嗪 | 5-Chloro Hydrochlorothiazide | C7H7Cl2N3O4S2 | |
4 | 129722-25-4 | 7-[4-[4-(2,3-二氯苯基)-1-哌嗪基]丁氧基]-2(1H)-喹啉酮 | DEHYDRO ARIPIPRAZOLE | C23H25Cl2N3O2 | |
5 | 480452-36-6 | 依度沙班杂质D | EthanediaMide iMpurity D | C21H30ClN5O5 | |
6 | 158812-85-2 | 奥美拉唑磺酰N-氧化物 | Omeprazole Sulfone N-Oxide | C17H19N3O5S | |
7 | 64858-90-8 | 氟比洛芬杂质 | Flurbiprofen Impurity | C17H17FO2 | |
8 | 953787-55-8 | 泮托拉唑砜N-氧化物 | PANTOPRAZOLE SULFONE N-OXIDE | C16H14F2N3O6S | |
9 | 159001-25-9 | 二氢脑甘露碱 | Dihydrocephalomannine | C45H55NO14 | |
10 | 1092578-48-7 | (3S,4R)-4-甲基-3-(甲基-7H-吡咯并[2,3-D]嘧啶-4-氨基)-BETA-氧代-1(托法替布杂质) | (3S,4R)-Tofacitinib | C16H20N6O | |
11 | 1239233-87-4 | 2-[3-羧基-4-(2-甲基丙氧基)苯基]-4-甲基-5-噻唑羧酸 | 2-[3-Carboxy-4-(2-methylpropoxy)phenyl]-4-methyl-5-thiazolecarboxylic Acid | C16H17NO5S | |
12 | 170571-01-4 | 羧酸塞来昔布 | CELECOXIB CARBOXYLIC ACID | C17H12F3N3O4S | |
13 | 60079-22-3 | 门冬氨酸鸟氨酸杂质B | ((S)-3-amino-3-carboxypropanoyl)-L-aspartic acid | C8H12N2O7 | |
14 | 847949-49-9 | O-去甲基吉非替尼 | O-Desmethyl Gefitinib | C21H22ClFN4O3 | |
15 | 4812-40-2 | 羟基甲硝唑 | Metronidazole-OH | C6H9N3O4 | |
16 | 573691-09-5 | 阿立哌唑-N1-氧化物 | Aripiprazole N1-Oxide | C23H27Cl2N3O3 | |
17 | 629652-72-8 | 他达拉非EP杂质B(ENT-他达拉非) | ent-Tadalafil | C22H19N3O4 | |
18 | 205826-86-4 | (R)-α - 〔(2,2-二甲基-1-氧代丙基)氨基] -4-羟基苯乙酸 | (R)-α-[(2,2-Dimethyl-1-oxopropyl)amino]-4-hydroxybenzeneacetic Acid | C13H17NO4 | |
19 | 105331-00-8 | 6-氨基-5-氮杂胞苷 | 6-Amino-5-azacytidine | C8H13N5O5 | |
20 | 187227-45-8 | 奥斯他伟酸 | OSELTAMIVIR ACID | C14H24N2O4 | |
21 | 1092578-47-6 | (3S,4S)-4-甲基-3-(甲基-7H-吡咯并[2,3-D]嘧啶-4-氨基)-BETA-氧代-1(托法替布杂质) | (3S,4S)-Tofacitinib | C16H20N6O | |
22 | 149709-44-4 | LCZ696杂质 | Sacubitrilat | C22H25NO5 | |
23 | 168110-44-9 | 米卡芬净杂质 FR-179642 | FR 179642 | C35H52N8O20S | 用途 米卡芬净杂质 FR-179642是一种脂肽化合物,可作为抗真菌剂,对曲霉和念珠菌具有活性。 |
24 | 149709-63-7 | LCZ 696杂质C | LCZ 696 Impurity C | C24H29NO5 | |
25 | 73837-24-8 | (1R,3S,5E)-4-亚甲基-5-[(2E)-2-[(1R,3AS,7AS)-八氢-1-[(1R | 5,6-trans-Calcitriol | C27H44O3 | |
26 | 1346600-54-1 | 6-甲基-N-(4-氨磺酰苯乙基)吡嗪-2-甲酰胺 (格列吡嗪杂质) | N-Des(cyclohexylaminocarbonyl) Glipizide | C14H16N4O3S | |
27 | 17592-07-3 | 速甾醇3 | (3beta,6E)-9,10-secocholesta-5(10),6,8-trien-3-ol | C27H44O | |
28 | 910129-15-6 | 5'-脱氧- 5 -氟-N -[(2-甲基丁)羰基]胞苷 | 5'-Deoxy-5-fluoro-N-[(2-methylbutoxy)carbonyl]cytidine | C15H22FN3O6 | |
29 | 2161380-87-4 | 5-溴-4-(4-氯噻吩-2-基)噻唑-2-胺 | 5-bromo-4-(4-chlorothiophen-2-yl)thiazol-2-amine | C7H4BrClN2S2 | |
30 | 104632-28-2 | R-普拉克索 | Dexpramipexole | C10H17N3S | |
31 | 174794-02-6 | 奥氮平杂质D | Olanzapine N-Oxide | C17H20N4OS | |
32 | 104632-27-1 | 普拉克索杂质D | Dexpramipexole dihydrochloride | C10H19Cl2N3S | Dexpramipexole dihydrochloride ((R)-Pramipexole dihydrochloride) 是神经保护剂,是弱的非麦角类多巴胺受体激动剂。 |
33 | 1379324-09-0 | 4,6-二氯-N-甲基-2-吡啶甲酰胺 | 4,6-Dichloro-N-methyl-2-pyridinecarboxamide | C7H6Cl2N2O | |
34 | 87375-91-5 | 3-异丁基-5-甲基2,6-二甲基-4-(2-亚硝基苯基)吡啶-3,5-二羧酸酯 | Dehydronitrosonisoldipine | C20H22N2O5 | |
35 | 19741-14-1 | 4-(((2,4-二氨基蝶呤-6-基)甲基)(甲基)氨基)苯甲酸 | 4-(((2,4-Diaminopteridin-6-yl)methyl)(methyl)amino)benzoic acid | C15H15N7O2 | |
36 | 1335202-59-9 | 非布索坦杂质J | 2-(4-(Sec-butoxy)-3-cyanophenyl)-4-methylthiazole-5-carboxylic acid | C16H16N2O3S | |
37 | 1657014-33-9 | 2-(4-丁氧基-3-氰基苯基)-4-甲基-5-噻唑羧酸 | 2-(4-Butoxy-3-cyanophenyl)-4-methylthiazole-5-carboxylic acid | C16H16N2O3S | |
38 | 1038924-70-7 | (3R,5S)-5-[(联苯基-4-基)甲基]-3-甲基吡咯烷-2-酮 | (3R,5S)-5-([1,1'-Biphenyl]-4-ylmethyl)-3-methylpyrrolidin-2-one | C18H19NO | |
39 | 1076199-40-0 | 奎硫平N -氧化物 | Quetiapine N-Oxide | C21H25N3O3S | |
40 | 170569-87-6 | 4-(5-苯基-3-(三氟甲基)-1H-吡唑-1-基)苯磺酰胺 | Desmethyl Celecoxib | C16H12F3N3O2S | |
41 | 581772-29-4 | 阿托伐他汀丙酮 | Atorvastatin acetonide | C36H39FN2O5 | |
42 | 1350352-70-3 | 2-[3-[(羟基亚氨基)甲基]-4-(2-甲基丙氧基)苯基]-4-甲基-5-噻唑羧酸 | Febuxostat impurity 7 | C16H18N2O4S | |
43 | 1640971-51-2 | 托法替尼代谢物-1 | Tofacitinib metabolite-1 | C16H20N6O2 | |
44 | 866157-50-8 | 奥扎格雷酯 | Ozagrel methylester | C13H12N2O2 | |
45 | 2230270-05-8 | 非布索坦杂质46 | ethyl 2-(4-butoxy-3-cyanophenyl)-4-methylthiazole-5-
carboxylate | C18H20N2O3S | |
46 | 2174002-16-3 | 帕布昔利布标准品025 | Palbociclib-025 | C25H29N7O3 | |
47 | 2223677-64-1 | 阿法替尼杂质DES-EJA | Afatinib Impurity des-EJA | C22H20ClFN4O3 | |
48 | 23500-10-9 | (S)-1-(2-氯乙酰基)-2-羧基吡咯 | CHLOROAC-PRO-OH | C7H10ClNO3 | |
49 | 571189-65-6 | 帕布昔利布杂质X | 4-[6-[(8-Cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino]pyridin-3-yl]piperazine-1-carboxylic acid tert-butyl ester | C27H35N7O3 | |
50 | 102804-77-3 | 雷贝拉唑4-甲氧基杂质 | 4-Desmethoxypropoxyl-4-methoxy Rabeprazole | C15H15N3O2S | |
51 | 668270-11-9 | 利拉利汀杂质G | Linagliptin iMpurity G | C25H28N8O2 | |
52 | 1884279-18-8 | 伐地昔布酸乙酯 | ethyl 4-(5-methyl-3-phenylisoxazol-4-yl)benzenesulfonate | C18H17NO4S | |
53 | 317807-10-6 | rac 4-去甲氧基-4-硝基奥美拉唑 | rac 4-Desmethoxy-4-nitro Omeprazole | C16H16N4O4S | |
54 | 117976-47-3 | 雷贝拉唑杂质E | Rabeprazole Sulfone | C18H21N3O4S | |
55 | 1408238-40-3 | 达比加群脂杂质C | Dabigatran Impurity 8 | C34H40N6O6 | |
56 | 220757-74-4 | 2-[[(4-氯-3,5-二甲基-2-吡啶基)甲基]硫基]-5-甲氧基苯并咪唑 | 4-Desmethoxy-4-chloro Omeprazole Sulfide | C16H16ClN3OS | |
57 | 211915-00-3 | 达比加群杂质J | Dabigatran iMpurity J | C33H39N7O5 | |